Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001810417-26-000023 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 18, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
37,182
Total Value
$324,890.12
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Sep 16, 2026 | Exercise/Conversion | 12,394 | $9.88 | $122,452.72 | 52,294 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Sep 16, 2026 | Sale | 12,394 | $16.33 | $202,437.40 | 39,900 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Sep 16, 2026 | Exercise/Conversion | 12,394 | $0.00 | $0.00 | 83,848 | Direct | โ | View Details |